Mimedx (MDXG) Profit After Tax (2011 - 2026)

Mimedx has disclosed Profit After Tax across 16 years of filings, most recently posting -$14.8 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 254.29% year-over-year to -$14.8 million; the TTM figure through Jun 2026 stood at $6.2 million (down 80.61% YoY), while the FY2025 annual figure was $48.6 million, up 14.52% from the prior year.
• Profit After Tax came in at -$14.8 million for Q2 2026 at Mimedx, down from -$10.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $51.3 million in Q4 2023 to a low of -$14.8 million in Q2 2026.
• Average Profit After Tax over 5 years is $5.3 million, with a median of $7.8 million recorded in 2024.
• Year-over-year, Profit After Tax plunged 602.42% in 2022 and jumped 12488.41% in 2023.
• Over 5 years, Profit After Tax stood at -$414000.0 in 2022, then jumped by 12488.41% to $51.3 million in 2023, then tumbled by 85.5% to $7.4 million in 2024, then surged by 104.24% to $15.2 million in 2025, then tumbled by 197.69% to -$14.8 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$14.8 million in Q2 2026, -$10.9 million in Q1 2026, and $15.2 million in Q4 2025.